Lycia Therapeutics Inc.

LYCA

Healthcare|Biotechnology|US

$30.50

+1.70 (+5.90%)

About

Lycia Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory, and allergic diseases. The company was founded in 2019 and is headquartered in South San Francisco, CA.

Stock Price

+1.7%(1Y)

1M

+1.7%

3M

+1.7%

6M

+1.7%

YTD

+1.7%

1Y

+1.7%

3Y

+1.7%

5Y

+1.7%

Pipeline Summary

1 total trials

1

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

Recruiting: 1

Active Trials (1)

Single Ascending and Multiple Ascending Dose Study of LCA-0061

NCT07701954Atopic Disease

Phase 1Recruiting

Enrollment: 72 participants

Key Facts

Market Cap$1.59B

Employees65

CEOAetna Wun Trombley

IPO DateOct 23, 2026

Beta0.00

52-Week Range$22.19 – $36.49

Avg Volume528,833

ExchangeNASDAQ

Websitelyciatx.com

Ownership

Float16.5%

Shares Outstanding52.1M

Recent Insider Trades

Venrock Healthcare Capital Partners III, L.P.BUY

Nov 2, 20268,305 shares @ $26.95

Venrock Healthcare Capital Partners III, L.P.BUY

Oct 30, 2026200 shares @ $26.86

Venrock Healthcare Capital Partners III, L.P.BUY

Oct 30, 20268,804 shares @ $26.27

Venrock Healthcare Capital Partners III, L.P.BUY

Oct 29, 20261,000 shares @ $26.33

Venrock Healthcare Capital Partners III, L.P.BUY

Oct 28, 20264,430 shares @ $25.97

Recent News

Lycia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Oct 26, 2026 · globenewswire.com

Forget Anthropic: Biotech Is Quietly Dominating the IPO Sphere

Oct 24, 2026 · barrons.com

U.S. IPO Weekly Recap: Trickle Of Biotech Activity Continues Amid Tech Sell-Off

Oct 24, 2026 · seekingalpha.com

Lycia Therapeutics Announces Pricing of Upsized Initial Public Offering

Oct 22, 2026 · globenewswire.com

Drug developer Lycia Therapeutics targets $938 million valuation in US IPO

Oct 20, 2026 · reuters.com

Data last updated: Nov 9, 2026, 04:20 AM